Value Lens: Gland Pharma may be cheaper than global firms but hovers above locals

By Ankit Agarwal

  • 16 Jul 2020
Premium
Credit: 123RF.com

The proposed initial public offering of Gland Pharma Ltd values the maker of injectable drugs at a premium to locally listed drugmakers but assigns a steep discount to overseas publicly listed companies, a VCCircle analysis shows. The Hyderabad-based company filed for the IPO earlier this month, barely three years after it ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.